Therapeutic Strategies for COVID

Name of grantee

Development Phase Supported

Environmental and Health Risk Management Plan (EHRMP)

Virchow Biotech Pvt Ltd

Immunotherapy of COVID infected patients using therapeutic antibodies from Human or Equine sources

Click Here

Bioklone Biotech Pvt L

Development of human monoclonal antibodies for SARS-Cov2 from convalescent patient blood

Click Here

Mazumdar Shaw Medical Foundation (MSMF)

Novel COV-trap Therapy to Reduce the Intensity of Covid-19 Infection

Click Here

Gennova Biopharmaceuticals Ltd

Therapeutic antibodies for COVID-19

Click Here